News & Updates

Show Multimedia Only
FLT3 inhibitor improves survival in patients with FLT3+ acute myeloid leukaemia

FLT3 inhibitor improves survival in patients with FLT3+ acute myeloid leukaemia

23 Aug 2022

Patients diagnosed with acute myeloid leukaemia with an FLT3 mutation (FLT3+ AML) may benefit from the addition of an FLT3 inhibitor to intensive chemotherapy postinduction by improving event-free (EFS) or overall survival (OS), suggests a study.

23 Aug 2022
Live birth after breast cancer may improve overall survival

Live birth after breast cancer may improve overall survival

22 Aug 2022 byRoshini Claire Anthony

Women who become pregnant and have a live birth following a diagnosis of breast cancer may have better overall survival (OS) outcomes than those without live births post-cancer, according to a study presented at ESHRE 2022.

22 Aug 2022
Rise in late-stage cervical cancer in SG linked to suboptimal screening uptake

Rise in late-stage cervical cancer in SG linked to suboptimal screening uptake

22 Aug 2022 byJairia Dela Cruz

Local researchers note a rising trend of late-stage cervical cancer in Singapore, a pattern that they say is likely to be an effect of a less than optimal uptake of screening for the disease.

22 Aug 2022